Why Do People Who Run Marathons Have Smaller Muscles?

The physical appearance of a marathon runner—lean, wiry, and notably lacking in large, bulky muscle—stands in stark contrast to the powerful physique of a sprinter or a bodybuilder. This difference is a precise biological outcome of the training stress applied to the body. The body remodels itself to meet the most frequent and intense demands placed upon it. For the marathon runner, that demand is sustained, low-intensity effort over many hours and miles, not maximal power or force. The resulting physique is optimized for endurance, adapting every system to be incredibly efficient at covering long distances with the least possible energy expenditure.

Training Specificity and the Demand for Efficiency

The principle of training specificity dictates that the body adapts exactly to the type of stress it encounters. Training for a marathon requires the ability to move a body mass over 26.2 miles, prioritizing “running economy,” which is the amount of oxygen required to maintain a given pace. Excess muscle tissue, known as hypertrophy, is metabolically expensive because it demands a constant supply of blood, oxygen, and calories, even when at rest.

The body actively selects against carrying this non-functional bulk for an endurance event. Each pound of non-essential muscle mass requires additional energy to transport throughout the race, lowering the athlete’s overall efficiency. Marathon training, therefore, pushes the body to shed unnecessary weight and structure that does not directly contribute to sustained forward momentum.

The goal is to create a lighter, more economical chassis capable of conserving energy for the final miles. This adaptive pressure ensures that the muscles are structured for sustained oxidation rather than for generating explosive, short-lived power. The physical outcome is a lean body composition with minimal fat and smaller, highly functional muscle mass.

The Internal Adaptations of Endurance Muscles

The difference in muscle size is structurally rooted in the type of muscle fibers that endurance training develops and favors. Skeletal muscle is composed of different fiber types, primarily Type I (slow-twitch) and Type II (fast-twitch). Type I fibers, which are the foundation of a marathon runner’s success, are naturally much smaller in diameter than their fast-twitch Type II counterparts.

Type I fibers are built for sustained aerobic activity and are highly resistant to fatigue, enabling them to contract repeatedly for hours. Elite marathon runners typically possess a higher percentage of these fibers, sometimes exceeding 70% in their legs, compared to the average person’s 45–55%. These fibers do not grow significantly larger because their adaptation focuses on improving oxygen processing, not increasing contractile force.

Endurance training drives several internal structural changes that improve sustained output without adding bulk. These adaptations include increased density of mitochondria. The concentration of myoglobin, a protein that stores and transports oxygen, also increases, giving these fibers a darker, “red” appearance. Furthermore, the network of capillaries surrounding the muscle fibers becomes denser, enhancing the delivery of oxygen and removal of waste products.

The surface-area-to-volume ratio of the muscle fiber also imposes a physical limit on size. A smaller diameter allows oxygen to diffuse more efficiently from the capillary to the fiber’s core. This optimization for aerobic function results in muscle that is smaller but vastly more efficient for long-distance running.

Metabolic and Hormonal Signals That Prevent Hypertrophy

The systemic chemical environment created by high-volume marathon training actively suppresses the pathways responsible for muscle growth, or hypertrophy. This effect is driven by the body’s constant struggle to meet the enormous energy demands of chronic exercise. Training for a marathon often results in a sustained, high caloric expenditure, which can lead to a chronic energy deficit that makes building new tissue nearly impossible.

The body’s energy sensor, an enzyme called Adenosine Monophosphate-activated Protein Kinase (AMPK), is repeatedly activated during long runs. When cellular energy stores are low, AMPK acts as a metabolic master switch, promoting energy production by breaking down fat and glycogen. Crucially, AMPK also suppresses the primary molecular signaling pathway for muscle growth, known as the mammalian Target of Rapamycin (mTOR).

By activating AMPK, the endurance runner’s body sends a strong molecular signal to halt energy-intensive processes like protein synthesis, which is necessary for muscle building. This molecular antagonism between the AMPK pathway (endurance/catabolism) and the mTOR pathway (strength/anabolism) ensures that the muscle adapts toward survival and efficiency rather than size.

The catabolic state is amplified by the hormonal environment, as the stress hormone cortisol elevates significantly during prolonged endurance exercise. Cortisol promotes the breakdown of tissues, including muscle protein, to provide amino acids for energy production. Concurrently, levels of anabolic hormones like testosterone decrease. This hormonal shift, combined with the AMPK-mTOR signaling, forms a powerful systemic barrier against muscle hypertrophy.